Fertility and Sterility
Volume 75, Issue 2 , Pages 324-331 , February 2001

A randomized prospective assessor-blind evaluation of luteinizing hormone dosage and in vitro fertilization outcome

  • Uma Deve Gordon, M.D. (M.R.C.O.G.,a)

      Affiliations

    • Human Assisted Reproduction Unit, Rotunda Hospital, Centre for Reproductive Medicine, University of Bristol, Bristol, United Kingdom
    • Corresponding Author InformationReprint requests: Uma Deve Gordon, M.D., M.R.C.O.G., Centre for Reproductive Medicine, University of Bristol, 4 Priory Road, Clifton, Bristol BS8 1TY, United Kingdom (FAX: 0117-9272792 )
    • ,
  • Robert F Harrison, M.D. (F.R.C.O.G., F.R.C.S., F.R.C.P.,b)

      Affiliations

    • Human Assisted Reproduction Unit, Rotunda Hospital, Human Assisted Reproduction Unit, Rotunda Hospital, Dublin, Ireland
    • ,
  • Medhat Fawzy (M.R.C.O.G.,c)

      Affiliations

    • Human Assisted Reproduction Unit, Rotunda Hospital, Assisted Conception Unit, Manchester, United Kingdom
    • ,
  • Benny Hennelly (R.C.N.,b)

      Affiliations

    • Human Assisted Reproduction Unit, Rotunda Hospital, Human Assisted Reproduction Unit, Rotunda Hospital, Dublin, Ireland
    • ,
  • Andrew C Gordon (M.Sc.d)

      Affiliations

    • Bath Assisted Conception Unit, Bath, United Kingdom

Received 6 March 2000 ,Revised 23 August 2000 ,Accepted 23 August 2000.

References 

  1. Armstrong DT, Dorrington JH. Oestrogen biosynthesis in the ovaries and testis. In:  Thomas JA,  Singhal RL editor. Regulatory mechanisms affecting gonadal hormone action. Vol. 2. Baltimore: University Park Press; 1979;p. 217–258
  2. Hodgen GD. Biological basis of follicle growth. Hum Reprod. 1989;4(Suppl):37–46
  3. Chappel SC, Howles C. Re-evaluation of the roles of luteinizing hormone and follicle-stimulating hormone in the ovulatory process. Hum Reprod. 1991;6:1206–1212
  4. Schoot DC, Coelingh-Bennink HJT, Mannaerts BMLJ, Lamberts SWJ, Bouchart P, Fauser BCJM. Human recombinant follicle stimulating hormone induces growth of preovulatory follicles without concomitant increase in androgen and oestrogen biosynthesis in a woman with isolated gonadotropin deficiency. J Clin Endocrinol Metab. 1992;74:1471–1473
  5. Homburg R, Armar NA, Eshel A, Adams J, Jacobs HS. Influence of serum luteinising hormone concentrations on ovulation, conception, and early pregnancy loss in polycystic ovary syndrome. Br Med J. 1988;297:1024–1026
  6. Watson H, Kiddy DS, Hamilton-Fairley D, Scanlon MJ, Barnard C, Collins WP, et al.  Hypersecretion of luteinizing hormone and ovarian steroids in women with recurrent early miscarriage. Hum Reprod. 1993;8:829–833
  7. Jacobson A, Marshall JR. Ovulatory response rate with human menopausal gonadotropins of varying FSH:LH ratios. Fertil Steril. 1969;20:171–175
  8. Bentick B, Shaw RW, Iffland CA, Burford G, Bernard A. A randomized comparative study of purified follicle stimulating hormone and human menopausal gonadotropin after pituitary desensitization with buserelin for superovulation and in vitro fertilization. Fertil Steril. 1988;50:79–84
  9. Hull MGR, Armatage RJ, McDermott A. Use of follicle stimulating hormone alone (urofollitropin) to stimulate the ovaries for assisted conception after pituitary desensitization. Fertil Steril. 1994;62:997–1003
  10. Daya S, Gunby J, Hughes EG, Collins JA, Sagle MA. Randomized controlled trial of follicle stimulating hormone versus human menopausal gonadotropin in in-vitro fertilization. Hum Reprod. 1995;10:1392–1396
  11. Check JH, O’Shaughnessy A, Nazari A, Hoover L. Comparison of efficacy of high dose pure follicle stimulating hormone versus human menopausal gonadotropins for in vitro fertilization. Gynecol Obstet Invest. 1995;40:117–119
  12. Giudice E, Crisci C, Eshkol A, Papoian R. Composition of commercial gonadotropin preparations extracted from human post-menopausal urine (characterization of non-gonadotropin proteins). Hum Reprod. 1994;9:2291–2299
  13. Keene JL, Matzuk MM, Otani T, Fauser BC, Galway AB, Hsueh AJ, et al.  Expression of biologically active human follitropin in Chinese hamster ovary cells. J Biol Chem. 1989;246:4769–4775
  14. Mannaerts B, de Leeuw R, Geelen J, van Ravestein A, van Wezenbeek P, Schuurs A, et al.  Comparative in vitro and in vivo studies on the biological characteristics of recombinant human follicle stimulating hormone. Endocrinology. 1991;129:2623–2630
  15. Daya S, Gunby J. Recombinant versus follicle stimulating hormone for ovarian stimulation in assisted reproduction. Hum Reprod. 1999;14:2207–2215
  16. World Health Organization . WHO laboratory manual for the examination of human semen and sperm-cervical mucus interaction. 3rd ed. Cambridge: Cambridge University Press; 1992;
  17. Cook AS, Webster BW, Terranova PF, Keel BA. Variation in the biological and biochemical characteristics of human menopausal gonadotropin. Fertil Steril. 1988;49:704–712
  18. Kondaveeti-Gordon U, Harrison RF, Barry-Kinsella C, Gordon AC, Drudy L, Cottell E. A randomized prospective study of early follicular or midluteal initiation of long protocol gonadotropin-releasing hormone in an in vitro fertilization program. Fertil Steril. 1996;66:582–586
  19. Harrison RF, Barry-Kinsella C, Drudy L, Gordon A, Hannon K, Hennelly B, et al.  An Irish out-patient based in-vitro fertilisation service. Ir Med J. 1992;85:63–65
  20. Sims JA, Feldman HJ, Muasher SJ. Early follicular rise of serum progesterone concentration in response to a flare up effect of gonadotropin-releasing hormone agonist impairs follicular recruitment for in-vitro fertilization. Hum Reprod. 1994;9:235–240
  21. Fried G, Harlin J, Csemiczky G, Wramsby H. Controlled ovarian stimulation using highly purified FSH results in a lower serum estradiol profile in the follicular phase as compared with hMG. Hum Reprod. 1996;11:474–477
  22. Shoham Z, Balen A, Patel A, Jacobs HS. Results of ovulation induction using human menopausal gonadotropins or purified follicle-stimulating hormone in hypogonadotropic hypogonadism patients. Fertil Steril. 1991;56:1048–1053
  23. Balasch J, Miro F, Burzaco I, Casamitjama R, Scivico S, Ballesca JL, et al.  The role of luteinizing hormone in human follicle development and oocyte fertility (evidence from in-vitro fertilization in a woman with long-standing hypogonadotropic hypogonadism and using recombinant human follicle stimulating hormone). Hum Reprod. 1995;10:1678–1683
  24. Parinaud J, Oustry P, Perineau M, Reme J-M, Monrozies X, Pontonnier G. Randomized trial of three luteinizing hormone-releasing hormone analogues used for ovarian stimulation in an in vitro fertilization program. Fertil Steril. 1992;57:1265–1268
  25. Scoccia B, Prins G, Blumenthal P, Scommegna A, Wagner C, Marut EL. Comparison of urinary human follicle stimulating hormone and human menopausal gonadotropins for ovarian stimulation in an in vitro fertilization program. Fertil Steril. 1987;46:446–449
  26. Daya S, Gunby J, Hughes EG, Collins JA, Sagle MA. Follicle stimulating hormone versus human menopausal gonadotropin for in vitro fertilization (results of a meta-analysis). Fertil Steril. 1995;64:347–354
  27. Hoomans EH, Andersen AN, Loft A, Leerentveld RA, van Kamp AA, Zech A. A prospective, randomized clinical trial comparing 150 IU recombinant follicle stimulating hormone (Puregon®) and 225 IU highly purified urinary follicle stimulating hormone (Metrodin-HP®) in a fixed-dose regimen in women undergoing ovarian stimulation. Hum Reprod. 1999;14:2442–2447
  28. Vermer HM, Saunders ALM. Amounts and composition of LH and HCG in two similar commercial hMG preparations. In:  Boutaleb Y,  Gzouli A editor. The study of ovulation and early pregnancy. Carnforth, UK: Parthenon Publications; 1991;p. 65–71
  29. De Leeuw R, Mulders J, Voortman G, Rombout F, Damm J, Klooster-Boer L. Structure-function relationship of recombinant follicle-stimulating hormone (Puregon). Mol Hum Reprod. 1996;2:361–369
  30. Wide L, Hobson BM. Influence of the assay method used on the selection of the most active forms of FSH from the human pituitary. Acta Endocrinol. 1986;113:17–22
  31. Mannaerts BMJL, Rombout F, Out HJ, Coelingh-Bennink H. Clinical profiling of recombinant follicle stimulating hormone (rFSH; Puregon) (relationship between serum FSH and efficacy). Hum Reprod Update. 1996;2:153–161
  32. Lambert A, Rodgers M, Mitchell R, Wood AM, Wardle C, Hilton B, et al.  In vitro biopotency and glycoform distribution of recombinant human follicle stimulating hormone (Org 32489), Metrodin and Metrodin-HP. Mol Hum Reprod. 1995;10:1928–1935
  33. Ulloa-Aguirre A, Midgley AR, Beitins I, Padmanabhan V. Follicle-stimulating isoforms (characterisation and physiological relevance). Endocr Rev. 1995;16:765–787
  34. European Recombinant Human LH Study Group . Recombinant human luteinising hormone (LH) to support recombinant human follicle-stimulating hormone (FSH)-induced follicular development in LH- and FSH-deficient anovulatory women (a dose-finding study). J Clin Endocrinol Metab. 1998;83:1507–1514
  35. Weston AM, Zelinski-Wooten MB, Hutchison JS, Stouffer RL, Wolf DP. Developmental potential of embryos produced by in vitro fertilization from gonadotropin-releasing hormone antagonist treated macaques stimulated with recombinant human follicle stimulating hormone alone or in combination with luteinizing hormone. Hum Reprod. 1996;11:608–613
  36. Hull MGR, Corrigan E, Piazzi A, Loumaye E. Recombinant human luteinising hormone (an effective new gonadotropin preparation). Lancet. 1994;344:334–335
  37. Chenette PE, Sauer MV, Paulson RJ. Very high serum estradiol levels are not detrimental to clinical outcome of in vitro fertilization. Fertil Steril. 1990;54:858–863
  38. Loumaye E, Engrand P, Howles CM, O’Dea L. Assessment of the role of serum luteinizing hormone and estradiol response to follicle stimulating hormone on in vitro fertilization outcome. Fertil Steril. 1997;67:889–899
  39. Gordon UD, Gordon AC, Harrison RFA. Randomized prospective study of the effect of LH on follicular fluid steroid concentrations. J Reprod Fertil 1997;26:16.
  40. Reshef E, Lei ZM, Rau CHV, Pridham DD, Chegnini N, Luborsky JL. The presence of gonadotropin receptors in non-pregnant uterus, human placenta, foetal membranes and decidua. J Clin Endocrinol Metab. 1990;70:421–430
  41. Meldrum DR, Wisot A, Hamilton F, Gultay-Yeo AL, Marr B, Huynh D. Artificial agonadism and hormone replacement for oocyte donation. Fertil Steril. 1989;52:509–511
  42. De Ziegler D, Cormel C, Bergeron C, Hazout A, Bouchard D, Frydman R. Controlled preparation of the endometrium with exogenous oestradiol and progesterone in women having functioning ovaries. Fertil Steril. 1991;56:851–858
  43. Li TC, Serle E, Warren MA, Cooke ID. Is endometrial development in the peri-implantation period influenced by high concentrations of luteinizing hormone in the follicular phase?. Hum Reprod. 1993;8:1021–1024
  44. Sills SE, Levy DP, Moomjy M, McGee M, Rosenwaks Z. A prospective, randomized comparison of ovulation induction using highly purified follicle-stimulating hormone alone and with recombinant human luteinizing hormone in in-vitro fertilization. Hum Reprod. 1999;14:2230–2235
  45. Agrawal R, Holmes J, Jacobs HS. Follicle-stimulating hormone or human menopausal gonadotropin for ovarian stimulation in in vitro fertilization cycles (a meta-analysis). Fertil Steril. 2000;73:338–343
  46. Ganirelix Dose-Finding Study Group . A double-blind, randomized, dose-finding study to assess the efficacy of the GnRH-antagonist Ganirelix (Org 37462) to prevent premature luteinizing hormone surges in women undergoing controlled ovarian hyperstimulation with recombinant follicle stimulating hormone. Hum Reprod. 1998;13:3023–3031
  47. Stanger JD, Yovich JL. Reduced in-vitro fertilisation of human oocytes from patients with raised basal luteinising hormone levels during the follicular phase. Br J Obstet Gynaecol. 1985;92:385–393
  48. Punnonen R, Ashorn R, Vilja P, Heinonen PK, Kujansuu E, Tuohimaa P. Spontaneous luteinizing hormone surge and cleavage of in vitro fertilized embryos. Fertil Steril 1988;479–82.
  49. Regan L, Owen EJ, Jacobs HS. Hypersecretion of luteinising hormone, infertility, and miscarriage. Lancet. 1990;336:1141–1144
  50. Thomas A, Okamoto S, O’Shea FO, MacLaughlin V, Vesanko M, Healy D. Do raised serum luteinising hormone levels during stimulation for in-vitro fertilisation predict outcome?. Br J Obstet Gynaecol. 1989;96:1328–1332
  51. Check JH, Peymer M, Lurie D, Suryanarayanan C. The relationship of early follicular phase serum LH and pregnancy rates in women with regular menses. Obstet Gynecol. 1996;87:291–296
  52. Carp HJA, Hass Y, Dolicky M, Goldenberg M, Mashiachia S, Rabinovici J. The effect of serum follicular phase luteinizing hormone concentrations in habitual abortion. Correlation with the results of paternal leukocyte immunization. Hum Reprod. 1995;10:1702–1705

PII: S0015-0282(00)01701-5

Fertility and Sterility
Volume 75, Issue 2 , Pages 324-331 , February 2001

Article Tools

* Image Usage & Resolution